![John R. Jaskowiak](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
John R. Jaskowiak
Director de Operaciones en Angiocrine Bioscience, Inc. .
Cargos activos de John R. Jaskowiak
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
Angiocrine Bioscience, Inc.
![]() Angiocrine Bioscience, Inc. Miscellaneous Commercial ServicesCommercial Services Angiocrine Bioscience, Inc. is a clinical-stage biotechnology company based on its novel and proprietary e-cel® platform. The company is based in San Diego, CA. The company is developing multiple e-cel therapies designed to repair damaged tissue from age-related degenerative disease of the musculoskeletal system, immune diseases that attack vessels and tissues, and ischemic diseases involving soft tissue, central nervous system, and the heart. The CEO of the company is Paul W. Finnegan. | Director de Operaciones | - | - |
Historial de carrera de John R. Jaskowiak
Estadísticas
Internacional
Estados Unidos | 2 |
Operativa
Chief Operating Officer | 1 |
Sectorial
Commercial Services | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
Empresas privadas | 1 |
---|---|
Angiocrine Bioscience, Inc.
![]() Angiocrine Bioscience, Inc. Miscellaneous Commercial ServicesCommercial Services Angiocrine Bioscience, Inc. is a clinical-stage biotechnology company based on its novel and proprietary e-cel® platform. The company is based in San Diego, CA. The company is developing multiple e-cel therapies designed to repair damaged tissue from age-related degenerative disease of the musculoskeletal system, immune diseases that attack vessels and tissues, and ischemic diseases involving soft tissue, central nervous system, and the heart. The CEO of the company is Paul W. Finnegan. | Commercial Services |
- Bolsa de valores
- Insiders
- John R. Jaskowiak
- Experiencia